MTOR and prostate carcinoma: These genes were downstream targets of mTOR signaling in prostate cancer.79 Moreover, the potent and ATP-competitive mTOR inhibitor repressed mRNA translation and suppressed cellular proliferation.80 Another study has revealed that mRNAs that are controlled by mTORC1 are 5’ terminal oligopyrimidine (TOP) motifs.